Clinical Trial Update: A Trial to Evaluate the Effect of C21 on Endothelial Dysfunction in Subjects With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 trial results for C21 in adults with type 2 diabetes assessed its effect on endothelial dysfunction; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endothelial Dysfunction
• Type 2 Diabetes Mellitus

Drugs mentioned

• C21 (C21)

Snippet

Sponsor: Vicore Pharma AB | Conditions: Type2diabetes, Endothelial Dysfunction | Phase 1 | Status: COMPLETED | Results posted: 2024-11-12